Fauci says he'll 'very likely' retire by the end of Biden's term
Infectious disease expert and political lightning rod Dr. Anthony Fauci said Monday that he will "very likely" retire by Jan. 2025, CNBC reports.
"By the time we get to the end of Biden's first term, I will very likely [retire]," Fauci told CNN on Monday. He elaborated during an interview with Politico published the same day. "If somebody says, 'You'll leave when we don't have Covid anymore,' then I will be 105. I think we're going to be living with this," the 81-year-old chief medical adviser said.
Fauci denied that the political animus he faces from the right was a factor in his decision to (probably) retire, but he did voice some frustrations. "It's becoming more and more difficult to get people to listen, because even the people who are compliant want [the pandemic] behind them," Fauci said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
When asked what he wants his legacy to be, Fauci did not mention COVID-19. Instead, he told Politico that "the most impactful thing I have done in my career" was his role in founding the President's Emergency Plan for AIDS Relief (PEPFAR) under former President George W. Bush. According to the State Department, PEPFAR has saved an estimated 21 million lives worldwide.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Grayson Quay was the weekend editor at TheWeek.com. His writing has also been published in National Review, the Pittsburgh Post-Gazette, Modern Age, The American Conservative, The Spectator World, and other outlets. Grayson earned his M.A. from Georgetown University in 2019.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published